|
|
Volumn 32, Issue 2, 2011, Pages 188-194
|
|
Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: A case series
a
|
|
Author keywords
Anti Xa; Anticoagulation; Enoxaparin; Low molecular weight heparin; Morbid obesity; Obesity
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 10A ANTIBODY;
CREATININE;
ENOXAPARIN;
PROTEIN ANTIBODY;
UNCLASSIFIED DRUG;
WARFARIN;
ADULT;
AGED;
ANTICOAGULANT THERAPY;
ARTICLE;
BLEEDING;
BODY MASS;
CASE STUDY;
CEREBROVASCULAR ACCIDENT;
CLINICAL ARTICLE;
CLINICAL EVALUATION;
COHORT ANALYSIS;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEART ATRIUM FIBRILLATION;
HUMAN;
KIDNEY DISEASE;
LOADING DRUG DOSE;
MALE;
MORBID OBESITY;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RECOMMENDED DRUG DOSE;
RETROSPECTIVE STUDY;
RISK ASSESSMENT;
THERAPY EFFECT;
THROMBOSIS;
TREATMENT DURATION;
VEIN THROMBOSIS;
VENOUS THROMBOEMBOLISM;
ADULT;
AGED;
BLOOD COAGULATION FACTOR INHIBITORS;
ENOXAPARIN;
EVALUATION STUDIES AS TOPIC;
FACTOR XA;
FEMALE;
FIBRINOLYTIC AGENTS;
HEMORRHAGE;
HUMANS;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
OBESITY, MORBID;
RETROSPECTIVE STUDIES;
VENOUS THROMBOEMBOLISM;
|
|
EID: 80052443962
PISSN: 09295305
EISSN: 1573742X
Source Type: Journal
DOI: 10.1007/s11239-011-0584-7 Document Type: Article |
|
Times cited : (37)
|
|
References (8)
|
